121 related articles for article (PubMed ID: 6761136)
1. Comparison of two doses of betaxolol and placebo in hypertension: a randomized, double-blind cross-over trial.
Salonen JT; Palminteri R
Eur J Clin Pharmacol; 1982; 23(6):491-4. PubMed ID: 6761136
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the antihypertensive effects of betaxolol to atenolol.
Mroczek WJ; Burris JF; Hogan LB; Citron DC; Barker AH; McDonald RH
Am J Cardiol; 1988 Apr; 61(10):807-11. PubMed ID: 2895577
[TBL] [Abstract][Full Text] [Related]
3. A comparison of betaxolol and nadolol on renal function in essential hypertension.
Bauer JH; Reams GP; Lau A
Am J Kidney Dis; 1987 Aug; 10(2):109-12. PubMed ID: 3300292
[TBL] [Abstract][Full Text] [Related]
4. [Treatment with betaxolol and placebo eyedrops in patients with glaucoma and reactive airway diseases].
Bleckmann H; Dorow P
Klin Monbl Augenheilkd; 1987 Sep; 191(3):199-202. PubMed ID: 2890791
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
Brügmann U; Blasini R
Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
[TBL] [Abstract][Full Text] [Related]
6. Comparison of betaxolol, a new beta 1-adrenergic antagonist, to propranolol in the treatment of mild to moderate hypertension.
Davidov ME; Glazer N; Wollam G; Zager PG; Cangiano J
Am J Hypertens; 1988 Jul; 1(3 Pt 3):206S-210S. PubMed ID: 2901266
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent effects of betaxolol in hypertension: a double-blind, multicenter study.
Williams RL; Goyle KK; Herman TS; Rofman BA; Ruoff GE; Hogan LB
J Clin Pharmacol; 1992 Apr; 32(4):360-7. PubMed ID: 1569238
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the antihypertensive effects of betaxolol and chlorthalidone as monotherapy and in combination.
Burris JF; Davidov ME; Jenkins P; Rofman B; Ginsberg D; Rosenbaum R; Ryan JR; Jain AK; Mroczek WJ
Arch Intern Med; 1989 Nov; 149(11):2437-41. PubMed ID: 2684073
[TBL] [Abstract][Full Text] [Related]
9. Betaxolol vs timolol. A six-month double-blind comparison.
Stewart RH; Kimbrough RL; Ward RL
Arch Ophthalmol; 1986 Jan; 104(1):46-8. PubMed ID: 3510612
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
Wong GW; Laugerotte A; Wright JM
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
[TBL] [Abstract][Full Text] [Related]
11. A double-masked comparison of betaxolol vs timolol in the treatment of open-angle glaucoma.
Allen RC; Hertzmark E; Walker AM; Epstein DL
Am J Ophthalmol; 1986 May; 101(5):535-41. PubMed ID: 3518464
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled, parallel-group, multicenter trial of four doses of tasosartan in patients with essential hypertension. Tasosartan Investigator's Group.
Lacourcière Y; Pool JL; Svetkey L; Gradman AH; Larochelle P; de Champlain J; Smith WB
Am J Hypertens; 1998 Apr; 11(4 Pt 1):454-61. PubMed ID: 9607384
[TBL] [Abstract][Full Text] [Related]
13. [Corneal sensitivity after single doses of timolol, betaxolol or placebo in persons with healthy eyes--a randomized, prospective double-blind study].
Höh H
Fortschr Ophthalmol; 1988; 85(2):132-8. PubMed ID: 2899042
[No Abstract] [Full Text] [Related]
14. Comparison of betaxolol with verapamil in hypertensive patients: discrepancy between office and ambulatory blood pressures.
Waeber G; Beck G; Waeber B; Bidiville J; Nussberger J; Brunner HR
J Hypertens; 1988 Mar; 6(3):239-45. PubMed ID: 3283227
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe hypertension with atenolol and betaxolol with once-daily regimens. Hemodynamic aspects.
Chrysant SG; Chrysant C; Bal IS; Trus J; Hitchcock A
Chest; 1989 Sep; 96(3):499-504. PubMed ID: 2569959
[TBL] [Abstract][Full Text] [Related]
16. Celiprolol in systemic hypertension.
Frishman WH; Flamenbaum W; Schoenberger J; Schwartz GL; Vidt DG; Neri GS; Greenberg S; Lazar E; Godfrey JC; Stevenson A
Am J Cardiol; 1989 Apr; 63(12):839-42. PubMed ID: 2522723
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
Germino FW
Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
[TBL] [Abstract][Full Text] [Related]
18. Systolic time intervals as possible predictors of pressure response to sustained beta-adrenergic blockade in arterial hypertension. A within-patient, placebo-controlled study.
Verdecchia P; Brignole M; Delfino G; Queirolo C; De Marchi G; Bertulla A
Hypertension; 1983; 5(1):140-6. PubMed ID: 6336719
[TBL] [Abstract][Full Text] [Related]
19. Manidipine versus enalapril monotherapy in patients with hypertension and type 2 diabetes mellitus: a multicenter, randomized, double-blind, 24-week study.
Luque Otero M; Martell Claros N;
Clin Ther; 2005 Feb; 27(2):166-73. PubMed ID: 15811479
[TBL] [Abstract][Full Text] [Related]
20. Comparison of bisoprolol with nifedipine for treatment of essential hypertension in the elderly: comparative double-blind trial.
Amabile G; Serradimigni A
Eur Heart J; 1987 Dec; 8 Suppl M():65-9. PubMed ID: 2967187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
